生物医学研究杂志（英文版）2021，Vol.35Issue(2)：115-134,20.
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
James B.Papizan 1Shaina N.Porter 2Akshay Sharma 1Shondra M.Pruett-Miller2
作者信息
- 1. Department of Cellular and Molecular Biology, St.Jude Children's Research Hospital, Memphis, TN 38105, USA
- 2. Center for Advanced Genome Engineering, St.Jude Children's Research Hospital, Memphis, TN 38105, USA
- 折叠
摘要
关键词
sickle cell disease/sickle cell anemia/fetal hemoglobin/hemoglobinopathy/CRISPR/gene editing/genome engineeringKey words
sickle cell disease/sickle cell anemia/fetal hemoglobin/hemoglobinopathy/CRISPR/gene editing/genome engineering分类
生物科学引用本文复制引用
James B.Papizan,Shaina N.Porter,Akshay Sharma,Shondra M.Pruett-Miller..Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies[J].生物医学研究杂志（英文版）,2021,35(2):115-134,20.
